ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Rapid overview for hypoglycemia in adults, other than significant sulfonylurea overdose

Rapid overview for hypoglycemia in adults, other than significant sulfonylurea overdose
Clinical features
  • Any patient with acute change in mental status or coma should undergo rapid assessment of blood glucose as a possible cause.
  • All findings of hypoglycemia are nonspecific, including the following:
    • Autonomic response (tends to occur with blood glucose below 65 mg/dL)
      • Sweating
      • Weakness
      • Tachycardia
      • Palpitations
      • Tremor
      • Nervousness
      • Hunger
      • Paresthesias
    • Neuroglycopenia
      • Irritability
      • Confusion
      • Uncharacteristic behavior
      • Seizure
      • Occasionally, transient focal neurologic deficits
      • Loss of consciousness
      • Visual disturbance
Diagnostic evaluation
  • Obtain blood glucose concentration as soon as possible (usually with a meter and strips, if available):
    • For symptomatic patient known to have diabetes and with a low glucose value (<70 mg/dL [3.89 mmol/L]), administer treatment. If a glucose test cannot be performed, do not delay. Treat as if hypoglycemia has been confirmed.
    • If the glucose is low (<55 mg/dL) and the patient does not have diabetes, draw blood for glucose, insulin, C-peptide, and an oral hypoglycemic agent screen, and then treat.
  • Do not delay treatment if symptomatic hypoglycemia is suspected but rapid blood glucose measurement is not available or blood for diagnostic studies cannot be collected.
Treatment
  • If the patient is conscious and able to drink and swallow safely (ie, alert enough to do so and with gag reflex intact), administer a rapidly absorbed carbohydrate (eg, 3 to 4 glucose tablets or a tube of gel with 15 grams, 4 to 6 oz fruit juice or non-diet soda, or a teaspoon of honey or table sugar).*
  • If the patient has altered mental status, is unable to swallow, or does not respond to oral glucose administration within 15 minutes, give an IV bolus of 12.5 to 25 g of glucose (25 to 50 mL of 50% dextrose).
  • Measure a blood glucose 10 to 15 minutes after the IV bolus. Re-administer 12.5 to 25 grams of glucose as needed to maintain the blood glucose above 80 mg/dL.
  • If glucose cannot be given by parenteral or oral routes, give glucagon 1 mg IM or subcutaneously. Response may be transient and should be followed by careful glucose monitoring and oral or IV glucose administration.
  • Give additional maintenance glucose by mouth or IV. IV dextrose infusion should ensure delivery of 6 to 9 mg/kg per minute of glucose. Amounts needed vary depending upon the cause and severity of the symptomatic hypoglycemia. Once the patient is able to ingest carbohydrate safely, providing a mixed meal (including carbohydrates, such as a sandwich) is the preferred means of maintaining glucose levels.
  • Measure a blood glucose 10 to 15 minutes after the initial IV bolus and monitor every 30 to 60 minutes thereafter until stable (minimum of 4 hours). The measurement method should provide rapid turnaround, preferably at the point of care.
  • Admit patients with ingestion of a long-acting hypoglycemic agent, recurrent hypoglycemia during observation, and those unable to eat.

IM: intramuscular; IV: intravenous.

* Patients taking an alpha-glucosidase inhibitor (eg, acarbose, miglitol, voglibose) with symptomatic hypoglycemia should only receive pure glucose (dextrose) orally because digestion and absorption of other carbohydrates (eg, table sugar [sucrose]) will be delayed by these medications and will be less effective in raising blood glucose levels.
Graphic 73797 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟